Skip to main content
. 2001 Feb;45(2):382–392. doi: 10.1128/AAC.45.2.382-392.2001

FIG. 1.

FIG. 1

Inhibition of CYP450 isoforms by INH at 50 μM (A) and 0 to 250 μM (B) in HLMs. The activity of each isoform was measured by isoform-specific substrate reaction probes at approximately their respective Km values: 60 μM for phenacetin O-deethylation (CYP1A2); 25 μM for dextromethorphan (CYP2D6); 25 μM for midazolam 4-hydroxylation (CYP3A); 50 μM for omeprazole (CYP2C19); 50 μM for tolbutamide (CYP2C9); and 25 μM for chlorzoxazone (CYP2E1). Data represent averages of duplicates.